Stockhub

NightHawk Biosciences, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

14 August 2022

13 August 2022

30 July 2022

  • curprev 12:5112:51, 30 July 2022‎ Chris talk contribs‎ 1,368 bytes +1,368‎ Created page with "NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate and expand T-cells; and ComPACT, which delivers antigen driven T-cell ac..." Tag: Visual edit
Retrieved from ‘https://stockhub.co/research/NightHawk_Biosciences,_Inc.’